CD44 Isoform 6 (CD44v6) Is a Prognostic Indicator of the Response to Neoadjuvant Chemotherapy in Cervical Carcinoma

Author: Costa S.   Terzano P.   Bovicelli A.   Martoni A.   Angelelli B.   Santini D.   Ceccarelli C.   Lipponen P.   Erzen M.   Syrjanen S.   Syrjanen K.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.80, Iss.1, 2001-01, pp. : 67-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content